Clinical trial
Averting Complications of Proton Pump Inhibitor Therapy by Effervescent Calcium Magnesium Citrate
NCT03812380 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Averting Complications of Proton Pump Inhibitor Therapy by Effervescent Calcium Magnesium Citrate
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- January 1, 2019
- Completion date
- August 11, 2021
- Enrollment
- 62 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypomagnesemia, osteoporosis